Your browser doesn't support javascript.
loading
Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.
Zhao, Chu-Biao; Bao, Ji-Ming; Lu, Yong-Jie; Zhao, Tong; Zhou, Xin-Hua; Zheng, Da-Yong; Zhao, Shan-Chao.
Afiliación
  • Zhao CB; Department of Urology and Medical Center for Overseas Patients, Nanfang Hospital, Southern Medical University Guangzhou, China.
  • Bao JM; Department of Urology and Medical Center for Overseas Patients, Nanfang Hospital, Southern Medical University Guangzhou, China.
  • Lu YJ; Molecular Oncology, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London London, UK.
  • Zhao T; Department of Pathology, School of Basic Medical Sciences, Southern Medical University Guangzhou, China.
  • Zhou XH; Department of Pathology, School of Basic Medical Sciences, Southern Medical University Guangzhou, China.
  • Zheng DY; Department of Oncology, Nanfang Hospital, Southern Medical University Guangzhou, China.
  • Zhao SC; Department of Urology and Medical Center for Overseas Patients, Nanfang Hospital, Southern Medical University Guangzhou, China.
Am J Cancer Res ; 4(4): 369-77, 2014.
Article en En | MEDLINE | ID: mdl-25057439
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2014 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2014 Tipo del documento: Article País de afiliación: China